APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease https://www.biorxiv.org/content/10.1101/2023.08.14.552850v1?med=mas
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease https://www.biorxiv.org/content/10.1101/2023.08.14.552850v1?med=mas